Novo Chief Executive Officer Lars Rebien Sorensen said he is in talks with the Greek government, which has ordered a 25 percent price cut on the Danish firm's insulins.
"What they propose right now is not acceptable," he said.
"It will have a rub-off effect on the European price level, and it has an effect on other markets outside Europe where the Greek prices are used as a reference price in negotiations with governments," Sorensen told Reuters.
via uk.reuters.com
No comments:
Post a Comment